المؤلفون: Choi IY; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD., Ling JP; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD.; Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD.; Kavli Neuroscience Discovery Institute, Johns Hopkins University, Baltimore, MD., Zhang J; Department of Biological Sciences, Columbia University, New York, NY., Helmenstine E; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD., Walter W; Munich Leukemia Laboratory, Munich, Germany., Tsakiroglou P; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD., Bergman RE; Division of Hematology, Oncology, Department of Medicine, Vanderbilt University Medical Center and The Vanderbilt-Ingram Cancer Center, Nashville, TN., Philippe C; Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Manley JL; Department of Biological Sciences, Columbia University, New York, NY., Rouault-Pierre K; Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Li B; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; MDS and MPN Centre, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China., Wiseman DH; Epigenetics of Haematopoiesis Laboratory, Division of Cancer Sciences, The University of Manchester, Manchester, United Kingdom.; Department of Haematology, The Christie NHS Foundation Trust, Manchester, United Kingdom., Batta K; Epigenetics of Haematopoiesis Laboratory, Division of Cancer Sciences, The University of Manchester, Manchester, United Kingdom.; Department of Haematology, The Christie NHS Foundation Trust, Manchester, United Kingdom., Ouseph M; Division of Pathology & Laboratory Medicine, Weill Cornell Medicine, New York, NY., Bernard E; Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY., Dubner B; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD., Li X; Department of Hematology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China., Haferlach T; Munich Leukemia Laboratory, Munich, Germany., Koget A; Division of Hematology and Cellular Therapy, Allegheny Health Network Cancer Institute, Pittsburgh, PA., Fazal S; Division of Hematology and Cellular Therapy, Allegheny Health Network Cancer Institute, Pittsburgh, PA., Jain T; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD., Gocke CD; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD.; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD., DeZern AE; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD., Dalton WB; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD.

المصدر: Blood advances [Blood Adv] 2024 Aug 13; Vol. 8 (15), pp. 3961-3971.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: RNA Splicing Factors*/genetics , RNA Splicing Factors*/metabolism , Myelodysplastic Syndromes*/genetics , Phosphoproteins*/genetics , RNA Splicing*, Humans ; Mutation ; Anemia, Sideroblastic/genetics ; Female ; Prognosis ; Aged ; Male

المؤلفون: Montoro MJ; Department of hematology, University Hospital Vall d´Hebron, Barcelona, BARCELONA, Spain., Palomo L; Institut Catala d'Oncololgia, Badalona, Spain., Haferlach C; MLL Munich Leukemia Laboratory, Munich, Germany., Acha P; Josep Carreras Leukaemia Research Institute, Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Barcelona, Spain., Chan O; Moffitt Cancer Center, Tampa, Florida, United States., Navarro V; Vall d'hebron Institute of Oncology (VHIO), Barcelona, Spain., Kubota Y; The University of Tokyo Hospital, Tokyo, Japan., Schulz FI; Universitätsklinikum Düsseldorf, Düsseldorf, Germany., Meggendorfer M; MLL Munich Leukemia Laboratory, Munich, Germany., Briski R; University of Texas MD Anderson Cancer Center, Houston, Texas, Houston, Texas, United States., Al-Ali N; H. Lee Moffitt Cancer Center, Tampa, Florida, United States., Xicoy B; Josep Carreras Leukemia Research Institute, Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Barcelona, Spain., Lopez F; Hospital del Mar, Barcelona, Spain., Bosch F; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., González T; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Department of Hematology Hospital Universitario de Salamanca, Salamanca, Spain., Eder LN; University of Goettingen, Goettingen, Germany., Jerez A; Hospital Morales Meseguer, Murcia, Spain., Wang YH; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan., Campagna A; IRCCS Humanitas Research Hospital & Humanitas University, Rozzano - Milan, Italy., Santini V; MDS Unit, University of Florence, Florence, Italy., Bernal Del Castillo T; Hospital Central de Asturia, ISPA, IUOPAs, Oviedo, Spain., Such E; Hospital Universitario y Politécnico La Fe, Valencia, Spain., Tien HF; National Taiwan University Hospital, Taipei, Taiwan., Díaz Varela N; Hospital Central de Asturia, ISPA, IUOPAs, oviedo, Spain., Platzbecker U; University Hospital Leipzig, Department of Hematology and Cell Therapy, Leipzig, Germany., Haase DT; University of Goettingen, Goettingen, Germany., Díez-Campelo M; COMPLEJO ASISTENCIAL UNIVERSITARIO DE SALAMANCA, Salamanca, Spain., Della Porta MG; IRCCS Humanitas Research Hospital & Humanitas University, Rozzano - Milan, Italy., Garcia-Manero G; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Wiseman DH; The University of Manchester, Manchester, United Kingdom., Germing U; Heinrich-Heine-University, Duesseldorf, Germany., Maciejewski JP; Cleveland Clinic, Cleveland, Ohio, United States., Komrokji RS; H. Lee Moffitt Cancer Center, Tampa, Florida, United States., Sole F; Institut de Recerca contra la Leucemia Josep Carreras. Barcelona, Spain, Badalona, Spain., Haferlach T; MLL Munich Leukemia Laboratory, Munich, Germany., Valcárcel D; Hospital Universitario Vall d'Hebron, Barcelona, Spain.

المصدر: Blood [Blood] 2024 Jul 29. Date of Electronic Publication: 2024 Jul 29.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

المؤلفون: Wang YH; Division of Cancer Sciences, Epigenetics of Haematopoiesis Laboratory, The University of Manchester, Manchester, UK.; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan., Lin CC; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan.; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan., Gurashi K; Division of Cancer Sciences, Epigenetics of Haematopoiesis Laboratory, The University of Manchester, Manchester, UK., Yao CY; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan.; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan., Jerez A; Haematology Department, Hospital Morales Meseguer, Murcia, Spain., Hou HA; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan., Chou WC; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan.; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan., Tien HF; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan.; Department of Internal Medicine, Far-Eastern Memorial Hospital, New Taipei City, Taiwan., Batta K; Division of Cancer Sciences, Epigenetics of Haematopoiesis Laboratory, The University of Manchester, Manchester, UK. kiran.batta@manchester.ac.uk., Wiseman DH; Division of Cancer Sciences, Epigenetics of Haematopoiesis Laboratory, The University of Manchester, Manchester, UK. daniel.wiseman@manchester.ac.uk.

المصدر: Blood cancer journal [Blood Cancer J] 2024 Jul 12; Vol. 14 (1), pp. 112. Date of Electronic Publication: 2024 Jul 12.

نوع المنشور: Letter

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

مواضيع طبية MeSH: Tumor Suppressor Protein p53*/genetics , Tumor Suppressor Protein p53*/metabolism , Leukemia, Myelomonocytic, Chronic*/genetics , Leukemia, Myelomonocytic, Chronic*/therapy , Leukemia, Myelomonocytic, Chronic*/diagnosis , Leukemia, Myelomonocytic, Chronic*/metabolism, Humans ; Prognosis ; Male ; Female ; Aged ; Middle Aged ; Aged, 80 and over

المؤلفون: Tentori CA; Humanitas Clinical and Research Center-IRCCS & Department of Biomedical Sciences Humanitas University Milan Italy.; Comprehensive Cancer Centre, King's College London UK., Zhao LP; Hématologie seniors Hôpital Saint-Louis, Assistance Publique des Hôpitaux de Paris (APHP) Paris France.; INSERM UMR_S1160, Institut de Recherche Saint Louis Université Paris Cité Paris France., Tinterri B; Humanitas Clinical and Research Center-IRCCS & Department of Biomedical Sciences Humanitas University Milan Italy., Strange KE; Comprehensive Cancer Centre, King's College London UK.; Research Group of Molecular Immunology Francis Crick Institute London UK., Zoldan K; Department of Medicine 1, Haematology, Cellular Therapy, Hemostaseology and Infectious Diseases University Medical Center Leipzig Leipzig Germany., Dimopoulos K; Department of Clinical Biochemistry Bispebjerg and Frederiksberg Hospital Copenhagen Denmark.; Department of Pathology, Rigshospitalet Copenhagen University Hospital Copenhagen Denmark., Feng X; Hematology Branch, National Heart, Lung and Blood Institute Bethesda Maryland USA., Riva E; Humanitas Clinical and Research Center-IRCCS & Department of Biomedical Sciences Humanitas University Milan Italy., Lim B; Imperial College London London UK., Simoni Y; Université Paris Cité, CNRS, INSERM, Institut Cochin Paris France., Murthy V; Centre for Clinical Haematology, University Hospitals of Birmingham Birmingham UK., Hayes MJ; Cell & Developmental Biology Vanderbilt University School of Medicine Nashville Tennessee USA.; Pathology, Microbiology and Immunology, Vanderbilt University Medical Center Nashville Tennessee USA.; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center Nashville Tennessee USA., Poloni A; Department of Clinical and Molecular Sciences Università Politecnica delle Marche Ancona Italy., Padron E; Moffitt Cancer Center, Malignant Hematology Department Tampa USA., Cardoso BA; Universidade Católica Portuguesa Faculdade de Medicina Portugal.; Universidade Católica Portuguesa, Centro de Investigação Interdisciplinar em Saúde Portugal., Cross M; Department of Medicine 1, Haematology, Cellular Therapy, Hemostaseology and Infectious Diseases University Medical Center Leipzig Leipzig Germany., Winter S; Medical Clinic I, University Hospital Carl Gustav Carus, TU Dresden Dresden Germany., Santaolalla A; Comprehensive Cancer Centre, King's College London UK., Patel BA; Hematology Branch, National Heart, Lung and Blood Institute Bethesda Maryland USA., Groarke EM; Hematology Branch, National Heart, Lung and Blood Institute Bethesda Maryland USA., Wiseman DH; Division of Cancer Sciences The University of Manchester Manchester UK.; The Christie NHS Foundation Trust Manchester UK., Jones K; Immunophenotyping Laboratory (Synnovis Analytics LLP) Southeast Haematological Malignancy Diagnostic Service, King's College Hospital London UK., Jamieson L; Immunophenotyping Laboratory (Synnovis Analytics LLP) Southeast Haematological Malignancy Diagnostic Service, King's College Hospital London UK., Manogaran C; Immunophenotyping Laboratory (Synnovis Analytics LLP) Southeast Haematological Malignancy Diagnostic Service, King's College Hospital London UK., Daver N; University of Texas MD Anderson Cancer Center Houston, Texas USA., Gallur L; Hematology Department, Vall d'hebron University Hospital, Vall d'hebron Institut of Oncology (VHIO) Vall d'Hebron Barcelona Hospital Campus Barcelona Spain., Ingram W; Department of Haematology University Hospital of Wales Cardiff UK., Ferrell PB; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center Nashville Tennessee USA.; Vanderbilt University Medical Center Nashville Tennessee USA., Sockel K; Medical Clinic I, University Hospital Carl Gustav Carus, TU Dresden Dresden Germany., Dulphy N; INSERM UMR_S1160, Institut de Recherche Saint Louis Université Paris Cité Paris France.; Laboratoire d'Immunologie et d'Histocompatibilité, Assistance Publique des Hôpitaux de Paris (APHP), Hôpital Saint-Louis Paris France.; Institut Carnot OPALE, Institut de Recherche Saint-Louis, Hôpital Saint-Louis Paris France., Chapuis N; Université Paris Cité, CNRS, INSERM, Institut Cochin Paris France.; Assistance Publique-Hôpitaux de Paris Centre, Hôpital Cochin Paris France., Kubasch AS; Department of Medicine 1, Haematology, Cellular Therapy, Hemostaseology and Infectious Diseases University Medical Center Leipzig Leipzig Germany., Olsnes AM; Section for Hematology, Department of Medicine Haukeland University Hospital Bergen Norway.; Department of Clinical Science Faculty of Medicine, University of Bergen Bergen Norway., Kulasekararaj A; Department of Haematology King's College Hospital, Denmark Hill London UK., De Lavellade H; Haematology Department Guy's and St Thomas NHS Trust London UK., Kern W; MLL Münchner Leukämielabor Munich Germany., Van Hemelrijck M; Comprehensive Cancer Centre, King's College London UK., Bonnet D; Hematopoietic Stem Cell Laboratory Francis Crick Institute London UK., Westers TM; Department of Hematology, Cancer Center Amsterdam Amsterdam University Medical Centers, location VU University Medical Center Amsterdam The Netherlands., Freeman S; Institute of Immunology and Immunotherapy University of Birmingham Birmingham UK., Oelschlaegel U; Medical Clinic I, University Hospital Carl Gustav Carus, TU Dresden Dresden Germany., Valcarcel D; Hematology Department, Vall d'hebron University Hospital, Vall d'hebron Institut of Oncology (VHIO) Vall d'Hebron Barcelona Hospital Campus Barcelona Spain., Raddi MG; Myelodysplastic Syndrome Unit, Hematology Division Azienda Ospedaliero-Universitaria Careggi, University of Florence Florence Italy., Grønbæk K; Department of Hematology, Rigshospitalet Copenhagen University Hospital Copenhagen Denmark.; Biotech Research and Innovation Center (BRIC) University of Copenhagen Copenhagen Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences University of Copenhagen Copenhagen Denmark., Fontenay M; Université Paris Cité, CNRS, INSERM, Institut Cochin Paris France.; Assistance Publique-Hôpitaux de Paris Centre, Hôpital Cochin Paris France., Loghavi S; University of Texas MD Anderson Cancer Center Houston, Texas USA., Santini V; Myelodysplastic Syndrome Unit, Hematology Division Azienda Ospedaliero-Universitaria Careggi, University of Florence Florence Italy., Almeida AM; Hematology Department Hospital da Luz Lisboa Lisboa Portugal.; Deanery Faculdade de Medicina, UCP Lisboa Portugal., Irish JM; Cell & Developmental Biology Vanderbilt University School of Medicine Nashville Tennessee USA.; Pathology, Microbiology and Immunology, Vanderbilt University Medical Center Nashville Tennessee USA.; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center Nashville Tennessee USA., Sallman DA; Moffitt Cancer Center, Malignant Hematology Department Tampa USA., Young NS; Hematology Branch, National Heart, Lung and Blood Institute Bethesda Maryland USA., van de Loosdrecht AA; Department of Hematology, Cancer Center Amsterdam Amsterdam University Medical Centers, location VU University Medical Center Amsterdam The Netherlands., Adès L; Hématologie seniors Hôpital Saint-Louis, Assistance Publique des Hôpitaux de Paris (APHP) Paris France.; Université Paris Cité, CNRS, INSERM, Institut Cochin Paris France., Della Porta MG; Humanitas Clinical and Research Center-IRCCS & Department of Biomedical Sciences Humanitas University Milan Italy., Cargo C; Leeds Teaching Hospital Leeds UK., Platzbecker U; Department of Medicine 1, Haematology, Cellular Therapy, Hemostaseology and Infectious Diseases University Medical Center Leipzig Leipzig Germany., Kordasti S; Comprehensive Cancer Centre, King's College London UK.; Department of Clinical and Molecular Sciences Università Politecnica delle Marche Ancona Italy.; Haematology Department Guy's and St Thomas NHS Trust London UK.

مؤلفون مشاركون: i4MDS consortium

المصدر: HemaSphere [Hemasphere] 2024 May 15; Vol. 8 (5), pp. e64. Date of Electronic Publication: 2024 May 15 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE

المؤلفون: Nicosia L; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, UK., Spencer GJ; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, UK., Brooks N; CellCentric Ltd., Cambridge CB10 1XL, UK., Amaral FMR; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, UK., Basma NJ; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, UK., Chadwick JA; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, UK., Revell B; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, UK., Wingelhofer B; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, UK., Maiques-Diaz A; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, UK., Sinclair O; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, UK., Camera F; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, UK., Ciceri F; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, UK., Wiseman DH; Epigenetics of Haematopoiesis Group, The University of Manchester, Manchester M20 4BX, UK., Pegg N; CellCentric Ltd., Cambridge CB10 1XL, UK., West W; CellCentric Ltd., Cambridge CB10 1XL, UK., Knurowski T; CellCentric Ltd., Cambridge CB10 1XL, UK., Frese K; CellCentric Ltd., Cambridge CB10 1XL, UK., Clegg K; CellCentric Ltd., Cambridge CB10 1XL, UK., Campbell VL; Western General Hospital, Edinburgh EH4 2XU, UK., Cavet J; The Christie NHS Foundation Trust, Manchester M20 4BX, UK., Copland M; Paul O'Gorman Leukaemia Research Centre, University of Glasgow, Glasgow G12 0YN, UK., Searle E; The Christie NHS Foundation Trust, Manchester M20 4BX, UK., Somervaille TCP; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4BX, UK; The Christie NHS Foundation Trust, Manchester M20 4BX, UK. Electronic address: tim.somervaille@cruk.manchester.ac.uk.

المصدر: Cancer cell [Cancer Cell] 2023 Dec 11; Vol. 41 (12), pp. 2136-2153.e13. Date of Electronic Publication: 2023 Nov 22.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE

مواضيع طبية MeSH: Nuclear Proteins* , Hematologic Neoplasms*/drug therapy , Hematologic Neoplasms*/genetics, Humans ; Cell Line, Tumor ; Transcription Factors ; Protein Domains ; E1A-Associated p300 Protein

المؤلفون: Wang YH; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan.; Epigenetics Haematopoiesis Laboratory, Division of Cancer Sciences, The University of Manchester, Manchester, UK., Lin CC; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan. jake9665@gmail.com.; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan. jake9665@gmail.com., Gurashi K; Epigenetics Haematopoiesis Laboratory, Division of Cancer Sciences, The University of Manchester, Manchester, UK., Wingelhofer B; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, Manchester, UK., Amaral FMR; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, Manchester, UK., Yao CY; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan.; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan., Hsieh HT; Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan., Liu MC; Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan., Hou HA; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan., Chou WC; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan.; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan., Batta K; Epigenetics Haematopoiesis Laboratory, Division of Cancer Sciences, The University of Manchester, Manchester, UK., Wiseman DH; Epigenetics Haematopoiesis Laboratory, Division of Cancer Sciences, The University of Manchester, Manchester, UK., Tien HF; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan. hftien@ntu.edu.tw.; Department of Internal Medicine, Fra-Eastern Memorial Hospital, New Taipei City, Taiwan. hftien@ntu.edu.tw.

المصدر: Leukemia [Leukemia] 2023 Dec; Vol. 37 (12), pp. 2507-2511. Date of Electronic Publication: 2023 Nov 02.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

مواضيع طبية MeSH: Myelodysplastic Syndromes*/drug therapy , Myelodysplastic Syndromes*/genetics, Humans ; Prognosis ; Azacitidine/pharmacology ; Azacitidine/therapeutic use

المؤلفون: Cortés-López M; New York Genome Center, New York, NY, USA; Division of Hematology and Medical Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA., Chamely P; New York Genome Center, New York, NY, USA; Division of Hematology and Medical Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA., Hawkins AG; Childhood Cancer Data Lab, Alex's Lemonade Stand Foundation, Philadelphia, PA, USA., Stanley RF; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Swett AD; New York Genome Center, New York, NY, USA; Division of Hematology and Medical Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA., Ganesan S; New York Genome Center, New York, NY, USA; Division of Hematology and Medical Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA., Mouhieddine TH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Dai X; Oxford Nanopore Technologies Inc., New York, NY, USA., Kluegel L; New York Genome Center, New York, NY, USA; Division of Hematology and Medical Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA., Chen C; New York Genome Center, New York, NY, USA; Division of Hematology and Medical Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA; Tri-Institutional MD-PhD Program, Weill Cornell Medicine, Rockefeller University, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Batta K; Division of Cancer Sciences, The University of Manchester, Manchester, UK., Furer N; Weizmann Institute of Science, Department of Molecular Cell Biology, Rehovot, Israel., Vedula RS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Beaulaurier J; Oxford Nanopore Technologies Inc., San Francisco, CA, USA., Drong AW; Oxford Nanopore Technologies Inc., New York, NY, USA., Hickey S; Oxford Nanopore Technologies Inc., San Francisco, CA, USA., Dusaj N; New York Genome Center, New York, NY, USA; Division of Hematology and Medical Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA; Tri-Institutional MD-PhD Program, Weill Cornell Medicine, Rockefeller University, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Mullokandov G; New York Genome Center, New York, NY, USA; Division of Hematology and Medical Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA., Stasiw AM; New York Genome Center, New York, NY, USA; Division of Hematology and Medical Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA., Su J; New York Genome Center, New York, NY, USA; Department of Systems Biology, Columbia University, New York, NY, USA., Chaligné R; Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Juul S; Oxford Nanopore Technologies Inc., New York, NY, USA., Harrington E; Oxford Nanopore Technologies Inc., New York, NY, USA., Knowles DA; New York Genome Center, New York, NY, USA; Department of Systems Biology, Columbia University, New York, NY, USA; Department of Computer Science, Columbia University, New York, NY, USA., Potenski CJ; New York Genome Center, New York, NY, USA; Division of Hematology and Medical Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA., Wiseman DH; Division of Cancer Sciences, The University of Manchester, Manchester, UK., Tanay A; Weizmann Institute of Science, Department of Computer Science and Applied Mathematics, Rehovot, Israel., Shlush L; Weizmann Institute of Science, Department of Molecular Cell Biology, Rehovot, Israel., Lindsley RC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Ghobrial IM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Taylor J; Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, FL, USA., Abdel-Wahab O; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Gaiti F; University Health Network, Princess Margaret Cancer Centre, Toronto, ON, Canada; University of Toronto, Medical Biophysics, Toronto, ON, Canada. Electronic address: federico.gaiti@uhn.ca., Landau DA; New York Genome Center, New York, NY, USA; Division of Hematology and Medical Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA. Electronic address: dlandau@nygenome.org.

المصدر: Cell stem cell [Cell Stem Cell] 2023 Sep 07; Vol. 30 (9), pp. 1262-1281.e8. Date of Electronic Publication: 2023 Aug 14.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101311472 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1875-9777 (Electronic) Linking ISSN: 18759777 NLM ISO Abbreviation: Cell Stem Cell Subsets: MEDLINE

مواضيع طبية MeSH: RNA Splice Sites* , Myelodysplastic Syndromes*/genetics , Myelodysplastic Syndromes*/metabolism, Humans ; Multiomics ; RNA Splicing/genetics ; RNA Splicing Factors/genetics ; RNA Splicing Factors/metabolism ; Mutation/genetics ; Phosphoproteins/genetics ; Phosphoproteins/metabolism

المؤلفون: Camera F; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, The Oglesby Cancer Research Centre Building, 555 Wilmslow Road, M20 4GJ Manchester, UK., Romero-Camarero I; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, The Oglesby Cancer Research Centre Building, 555 Wilmslow Road, M20 4GJ Manchester, UK., Revell BH; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, The Oglesby Cancer Research Centre Building, 555 Wilmslow Road, M20 4GJ Manchester, UK., Amaral FMR; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, The Oglesby Cancer Research Centre Building, 555 Wilmslow Road, M20 4GJ Manchester, UK., Sinclair OJ; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, The Oglesby Cancer Research Centre Building, 555 Wilmslow Road, M20 4GJ Manchester, UK., Simeoni F; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, The Oglesby Cancer Research Centre Building, 555 Wilmslow Road, M20 4GJ Manchester, UK., Wiseman DH; Epigenetics of Haematopoiesis Group, Oglesby Cancer Research Building, The University of Manchester, M20 4GJ Manchester, UK., Stojic L; Centre for Cancer Cell and Molecular Biology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, EC1M 6BQ London, UK., Somervaille TCP; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, The Oglesby Cancer Research Centre Building, 555 Wilmslow Road, M20 4GJ Manchester, UK.

المصدر: IScience [iScience] 2023 Jul 11; Vol. 26 (8), pp. 107319. Date of Electronic Publication: 2023 Jul 11 (Print Publication: 2023).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101724038 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-0042 (Electronic) Linking ISSN: 25890042 NLM ISO Abbreviation: iScience Subsets: PubMed not MEDLINE

المؤلفون: Huerga Encabo H; Haematopoietic Stem Cell Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK. Electronic address: hector.encabo@crick.ac.uk., Aramburu IV; Laboratory of Antimicrobial Defence, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Garcia-Albornoz M; Haematopoietic Stem Cell Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Piganeau M; Haematopoietic Stem Cell Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Wood H; Haematopoietic Stem Cell Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Song A; Haematopoietic Stem Cell Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Ferrelli A; Haematopoietic Stem Cell Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Sharma A; Haematopoietic Stem Cell Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Minutti CM; Immunobiology Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Domart MC; Electron Microscopy Science Technology Platform, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Papazoglou D; Haematopoietic Stem Cell Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Gurashi K; Division of Cancer Sciences, The University of Manchester, Manchester, UK., Llorian Sopena M; Bioinformatics and Biostatistics, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Goldstone R; Bioinformatics and Biostatistics, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Fallesen T; Advanced Light Microscopy Science Technology Platform, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Wang Q; Laboratory of Antimicrobial Defence, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Ariza-McNaughton L; Haematopoietic Stem Cell Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Wiseman DH; Division of Cancer Sciences, The University of Manchester, Manchester, UK., Batta K; Division of Cancer Sciences, The University of Manchester, Manchester, UK., Gupta R; Haematology Stem Cell Group, UCL Cancer Institute, London, UK., Papayannopoulos V; Laboratory of Antimicrobial Defence, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK. Electronic address: veni.papayannopoulos@crick.ac.uk., Bonnet D; Haematopoietic Stem Cell Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK. Electronic address: dominique.bonnet@crick.ac.uk.

المصدر: Cell stem cell [Cell Stem Cell] 2023 Jun 01; Vol. 30 (6), pp. 781-799.e9.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101311472 Publication Model: Print Cited Medium: Internet ISSN: 1875-9777 (Electronic) Linking ISSN: 18759777 NLM ISO Abbreviation: Cell Stem Cell Subsets: MEDLINE

مواضيع طبية MeSH: Neutrophils* , Dioxygenases*/genetics, Humans ; Mice ; Animals ; Proto-Oncogene Proteins ; Hematopoietic Stem Cells/physiology ; Bone Marrow ; Hematopoiesis/genetics ; Mutation ; DNA-Binding Proteins/genetics

المؤلفون: Wang YH; Division of Cancer Sciences, The University of Manchester, Manchester, UK.; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan.; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, Manchester, UK., Yao CY; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan.; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan., Lin CC; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan.; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan., Gurashi K; Division of Cancer Sciences, The University of Manchester, Manchester, UK., Amaral FMR; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, Manchester, UK., Bossenbroek H; Division of Cancer Sciences, The University of Manchester, Manchester, UK., Jerez A; Haematology Department, Hospital Morales Meseguer, Murcia, Spain., Somervaille TCP; Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, Manchester, UK., Binder M; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Patnaik MM; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Hou HA; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan., Chou WC; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan.; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan., Batta K; Division of Cancer Sciences, The University of Manchester, Manchester, UK., Wiseman DH; Division of Cancer Sciences, The University of Manchester, Manchester, UK., Tien HF; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan.; Department of Internal Medicine, Fra-Eastern Memorial Hospital, New Taipei City, Taiwan.

المصدر: British journal of haematology [Br J Haematol] 2023 Apr; Vol. 201 (2), pp. 302-307. Date of Electronic Publication: 2023 Feb 06.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myelomonocytic, Chronic*/diagnosis , Leukemia, Myelomonocytic, Chronic*/genetics , Myelodysplastic Syndromes* , Leukemia, Myeloid, Acute*, Humans ; Prognosis ; Stem Cells